Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

The humoral immunity after SARS-CoV-2 infection or vaccination was examined. Convalescent sera after infection with variants of concern (VOCs: B.1.1.7, <i>n</i> = 10; B.1.351, <i>n</i> = 1) and sera from 100 vaccinees (Pfizer/BioNTech, BNT162b2, <i>n</i> = 33; Mod...

Full description

Bibliographic Details
Main Authors: Franziska Neumann, Ruben Rose, Janine Römpke, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
COVID-19
virus variants
vaccination
humoral immune response
IgG
titer
Online Access:https://www.mdpi.com/2076-393X/9/7/700

Internet

https://www.mdpi.com/2076-393X/9/7/700

Similar Items